Don’t let the high cost of brand every-2-month schizophrenia and bipolar I injection disrupt your treatment. We help eligible patients access Abilify Asimtufii (aripiprazole extended-release IM injection) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
The Abilify Asimtufii Patient Assistance Program helps eligible patients access this every-2-month aripiprazole injectable at little or no cost when meeting income, insurance, and clinical criteria.
At AffordMyPrescriptions, our Patient Advocates handle the entire Abilify Asimtufii PAP enrollment for a flat $69.95 per month — so you never face a gap in Abilify Asimtufii schizophrenia or bipolar I therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Abilify Asimtufii enrollment — so you never face a gap in your every-2-month injectable psychiatric therapy.
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Generic oral aripiprazole | ~$15/mo | Very cheap oral alt |
| Specialty pharmacy | ~$4,000/2-mo | Save substantially |
| Psychiatric clinic | ~$4,500/2-mo | Save substantially |
| Hospital pharmacy | ~$5,000/2-mo | Save substantially |
| 340B community mental health | ~$3,500/2-mo | Save substantially |
| Abilify Maintena (monthly) | ~$1,900/mo | Related monthly LAI |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Abilify Asimtufii — independent of dosage or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Abilify Asimtufii Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy. Every-2-month dosing dramatically reduces required medical visits and improves adherence. Generic oral aripiprazole is very cheap for patients preferring daily oral. Community mental health centers often facilitate LAI programs.
Complete a simple eligibility form so our team can determine if you may qualify for Abilify Asimtufii assistance.
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Once approved, your Abilify Asimtufii is delivered through the assistance program while we manage refills and annual renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Abilify Asimtufii:
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $4,000–$5,000/2-mo per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Fixed $69.95/month — never changes regardless of retail price
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Abilify Asimtufii assistance.
Abilify Asimtufii is the longest-interval aripiprazole long-acting injectable — every-2-month IM dosing. Same aripiprazole molecule as Abilify Maintena (monthly) delivered in every-2-month formulation. Reduces required medical contact and improves adherence.
How It Works:
Schizophrenia and bipolar I disorder are chronic conditions requiring long-term antipsychotic therapy. Adherence to daily oral antipsychotics is challenging — nonadherence is a major driver of relapse, hospitalization, and poor long-term outcomes. Long-acting injectable (LAI) antipsychotics ensure therapeutic drug levels for weeks to months. Aripiprazole is a partial dopamine D2 receptor agonist and 5-HT1A partial agonist / 5-HT2A antagonist. Abilify Maintena is monthly IM aripiprazole LAI. Abilify Asimtufii extends dosing interval to every 2 months. Requires prior tolerability confirmation on oral aripiprazole or Abilify Maintena.
Form and Use:
Abilify Asimtufii IM injection in gluteal muscle every 2 months. Dose based on prior stable Abilify Maintena or oral aripiprazole. Requires prior tolerability confirmation. Given at psychiatric clinic or community mental health center. Refrigerate before use.
Generic Availability:
No generic Abilify Asimtufii. Related aripiprazole LAIs: Abilify Maintena (monthly IM), Aristada (aripiprazole lauroxil monthly IM). Oral aripiprazole (generic — very cheap for daily dosing). Other long-acting injectable antipsychotics: paliperidone family — Invega Sustenna (monthly IM), Invega Trinza (3-monthly IM), Invega Hafyera (6-monthly IM); Risperdal Consta (risperidone IM every 2 weeks — brand and generic), Perseris, Uzedy, Zyprexa Relprevv. Multiple oral antipsychotic generics: risperidone, olanzapine, quetiapine, aripiprazole, paliperidone, ziprasidone.
Warnings:
Increased mortality in elderly patients with dementia-related psychosis (BOXED WARNING for all antipsychotics — not approved for this indication), suicidal thoughts and behaviors in young adults, neuroleptic malignant syndrome (rare but serious), tardive dyskinesia, metabolic effects, akathisia (common with aripiprazole), impulse control problems (pathologic gambling, compulsive shopping, hypersexuality, binge eating), orthostatic hypotension. Other: injection site reactions, weight gain (less than other antipsychotics), sedation, insomnia. Long-acting formulation means effects may persist weeks after last dose. Coordinate with psychiatrist for monitoring.
$4,000–$5,000 per every-2-month injection at specialty pharmacies or psychiatric clinics. Amortized monthly cost $2,000–$2,500. Abilify Maintena (monthly LAI) $1,800–$2,000 per month. Generic oral aripiprazole $10–$20 per month. LAI advantage is adherence, not cost per month.
Same aripiprazole molecule. Abilify Maintena is monthly IM injection. Abilify Asimtufii is every-2-month IM injection — longest-interval aripiprazole LAI. Requires prior tolerability on oral aripiprazole or Abilify Maintena. Every-2-month dosing dramatically reduces required medical visits.
Both are long-acting aripiprazole. Aristada is aripiprazole lauroxil ester monthly IM. Abilify Asimtufii is aripiprazole every-2-month IM. Slight differences in pharmacokinetics. Both effective; choice by prescriber preference and insurance.
Adherence — daily oral nonadherence drives schizophrenia and bipolar relapse, hospitalization, and poor outcomes. LAIs guarantee therapeutic drug levels for weeks/months. Abilify Asimtufii every-2-month dosing = 6 medical visits per year rather than daily pill-taking.
Akathisia (very common with aripiprazole), weight gain (less than other atypicals), sedation, insomnia, injection site reactions. Impulse control problems (pathologic gambling, compulsive shopping, hypersexuality, binge eating). Rare: NMS, tardive dyskinesia, orthostatic hypotension. Long-acting formulation means effects may persist weeks after last dose.
Every-2-month injectable psychiatric therapy transforms adherence and outcomes. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.